|
|
Effect of Ropivacaine combined with Sufentanil or Fentanyl in labor analgesia |
WU Yu1 XU Yiming2 SUN Yu’e1 YANG Xuli1▲ |
1.Department of Anesthesiology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Jiangsu Province, Nangjing 221008, China; 2.Department of Anesthesiology, Suzhou Municipal Hospital, Jiangsu Province, Suzhou 215000, China |
|
|
Abstract Objective To explore the effect of Ropivacaine combined with Sufentanil or Fentanyl in labor analgesia. Methods Ninety healthy pregnant women who underwent labor analgesia in the Affliated Drum Tower Hospital of Nanjing University Medical School from August 2017 to August 2020 were selected as subjects. They were divided into study group (45 cases, given Ropivacaine combined with Sufentanil for epidural labor anesthesia) and control group (45 cases, given Ropivacaine combined with Fentanyl for epidural labor anesthesia). The pain conditions of 5, 20, 40, and 60 min analgesia were compared between two groups; the labor time of two groups was recorded. Apgar scores 1 and 5 minutes after birth were measured of two groups; the adverse reactions of two groups were observed. Results Comparison of numerical rating scale (NRS) scores at different time points between two groups showed statistically significant differences (P<0.05); the NRS scores of study group were lower than those of control group at 20, 40, and 60 min analgesia (P<0.05). The first stage of labor and the second stage of labor in study group were shorter than those in control group (P<0.05). There was no significant difference in Apgar score 1 and 5 min after birth (P>0.05). There was no significant difference in the total incidence of adverse reactions between two groups (P>0.05). Conclusion The analgesic effect of Ropivacaine combined with Sufentanil in perinatal labor is better than that of Ropivacaine combined with Fentanyl and helps shorten the first stages of labor and second stages of labor.
|
|
|
|
|
[1] 罗树志,李倩倩,赵继丽,等.硬膜外分娩镇痛中基于镇痛评分调控镇痛药物剂量临床效果观察[J].山东医药,2020,60(36):49-51.
[2] 江芳,祝昌美.分娩镇痛仪镇痛对产妇产程及胎儿窘迫的影响[J].深圳中西医结合杂志,2020,30(23):30-31.
[3] 莫国惠,林中原,刘德成,等.硬膜外镇痛不同给药方式对分娩结局影响的网状Meta分析[J].实用医学杂志,2020, 36(24):3378-3384.
[4] 凌申英.硬膜外阻滞镇痛不同时机的选择对产程的影响[J].中外医学研究,2018,16(13):156-158.
[5] 刘梅,侯玉萍.镇痛分娩临床应用的研究进展[J].医学综述,2019,25(24):150-154.
[6] 严广斌.NRS疼痛数字评价量表numerical rating scale[J].中华关节外科杂志(电子版),2014,8(3):410.
[7] 周燕,罗建刚,关秀莹,等.无痛分娩技术在产科临床分娩中的应用价值[J].中国当代医药,2020,27(8):96-98.
[8] 吴玉红,沈贵荣,阮军,等.产后早期爱丁堡产后抑郁量表评分对产后抑郁症的预测性分析[J].现代保健:医学创新研究,2008,5(17):1-3.
[9] 江秀敏,黄欣欣,金丽珠,等.阴道分娩疼痛变化趋势及其影响因素分析[J].中国现代医学杂志,2018,28(11):54-59.
[10] 代虹,韩新,吕袁凯,等.程控硬膜外脉冲式输注不同剂量罗哌卡因复合舒芬太尼行阶梯式分娩镇痛对母婴的影响[J].临床麻醉学杂志,2020,36(10):975-979.
[11] 晏明,张玉凤,李晓琼,等.硬脊膜穿破硬膜外阻滞与直接硬膜外阻滞在分娩镇痛中的应用比较[J].中国医药导报,2020,17(36):181-184.
[12] 罗丽兰,吴岸晓,王丽婷.不同时机实施分娩镇痛对初产妇产程,分娩方式及新生儿结局的影响[J].医学理论与实践,2021,34(19):3417-3419.
[13] 房建,赵继蓉.小剂量罗哌卡因联合舒芬太尼腰硬联合麻醉在无痛分娩中的应用[J].中华全科医学,2018,16(2):264-267.
[14] 周建敏,胡中坤,陈赛丹,等.纳布啡与舒芬太尼在后腹膜镜术后镇痛效果的比较[J].临床麻醉学杂志,2019, 35(12):1178-1180.
[15] 潘建华,苏惠斌,鲁刚,等.不同浓度盐酸纳布啡混合舒芬太尼术后自控静脉镇痛对妇科肿瘤开腹术病人炎症反应的影响[J].中华麻醉学杂志,2019,39(11):1340- 1343.
[16] 曹家刚,李胜华,冯迪,等.不同浓度罗哌卡因复合舒芬太尼分娩镇痛对产妇产间发热的影响[J].临床麻醉学杂志,2019,35(4):327-330.
[17] 王鑫,夏涵,李斌,等.罗哌卡因复合舒芬太尼持续硬膜外麻醉对无痛分娩镇痛效果及母婴状况的影响[J].现代生物医学进展,2018,18(7):1293-1296.
[18] 董华,邢相记.舒芬太尼复合罗哌卡因硬膜外麻醉在子宫切除术患者中的效果观察[J].中国药物与临床,2021, 21(13):2328-2330.
[19] 谭素云,黄霄行,韩全国.罗哌卡因复合舒芬太尼硬膜外和腰硬联合阻滞用于无痛分娩的临床观察[J].中外医学研究,2014,12(10):32-33.
[20] 赵艳萍,张望平.小剂量吗啡复合罗哌卡因用于硬膜外分娩镇痛的效果[J].中国现代应用药学,2019,36(9):1137-1139.
[21] 罗青妍,焦静,黄绍强,等.0.15%罗哌卡因与0.1%罗哌卡因复合舒芬太尼硬膜外分娩镇痛的比较[J].临床麻醉学杂志,2020,36(8):58-62.
[22] 阮霞,李爱媛,陈锋,等.罗哌卡因复合舒芬太尼在潜伏期分娩镇痛中的应用效果[J].现代生物医学进展,2017, 17(7):1266-1269.
[23] 唐斌,余德.罗哌卡因复合舒芬太尼硬膜外麻醉对分娩产妇疼痛程度及应激状态的影响[J].空军医学杂志,2018, 34(2):104-106,114.
[24] 杨远平,谢初仁,彭玉琴.罗哌卡因加舒芬太尼硬膜外麻醉分娩镇痛中的应用[J].辽宁医学杂志,2019,33(1):36-38.
[25] 王润,黄立锋,刘文胜,等.舒芬太尼复合不同浓度罗哌卡因硬膜外阻滞在产程潜伏期阶梯式分娩镇痛中的效果观察[J].中国性科学,2019,28(7):61-65.
[26] 王超,叶光磊,徐鑫怡,等.轻比重罗哌卡因复合舒芬太尼在剖宫产术中最佳剂量分析[J].临床和实验医学杂志,2021,20(8):890-893.
[27] 宋歌.盐酸罗哌卡因联合舒芬太尼麻醉对分娩镇痛产妇的应用效果[J].中国医药科学,2022,12(9):153-156. |
|
|
|